All Relations between sn and Substantia nigra

Publication Sentence Publish Date Extraction Date Species
A Chocyk, A Przyborowska, D Dudys, I Majcher, M Maćkowiak, K Wędzon. The impact of maternal separation on the number of tyrosine hydroxylase-expressing midbrain neurons during different stages of ontogenesis. Neuroscience. vol 182. 2012-05-31. PMID:21396433. we included in the study the sub-regions of the substantia nigra (sn) and the ventral tegmental area (vta). 2012-05-31 2023-08-12 rat
Supriya Swarnkar, Sarika Singh, Sharad Sharma, Ramesh Mathur, Ishan K Patro, Chandishwar Nat. Rotenone induced neurotoxicity in rat brain areas: a histopathological study. Neuroscience letters. vol 501. issue 3. 2012-05-31. PMID:21435374. striatum (str) and substantia nigra (sn) using he (hematoxylin and eosin) and cv (cresyl violet) staining after 1, 7, and 14 day of unilateral intranigral administration of rotenone (3, 6 and 12 μg/5 μl) in adult male sd rats. 2012-05-31 2023-08-12 rat
Qing He, Tingting Du, Xiaojun Yu, Anmu Xie, Ning Song, Qi Kang, Jintai Yu, Lan Tan, Junxia Xie, Hong Jian. DMT1 polymorphism and risk of Parkinson's disease. Neuroscience letters. vol 501. issue 3. 2012-05-31. PMID:21777657. growing evidence suggests that iron accumulation in the substantia nigra (sn) is involved in the pathology of parkinson's diseases (pd). 2012-05-31 2023-08-12 human
Sara Al-Sweidi, Marc Morissette, Mélanie Bourque, Thérèse Di Paol. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease. Neuropharmacology. vol 61. issue 4. 2012-05-25. PMID:21586296. specific radioligand binding autoradiography and in situ hybridization for dat, vmat2 and th were assayed in the striatum and the substantia nigra (sn). 2012-05-25 2023-08-12 mouse
Hsin-Yi Huang, Shinn-Zong Lin, Wu-Fu Chen, Kuo-Wei Li, Jon-Son Kuo, Mei-Jen Wan. Urocortin modulates dopaminergic neuronal survival via inhibition of glycogen synthase kinase-3β and histone deacetylase. Neurobiology of aging. vol 32. issue 9. 2012-05-17. PMID:19875195. although ucn is principally expressed in dopaminergic neurons in rat substantia nigra (sn), the function of ucn in modulating dopaminergic neuronal survival remains unclear. 2012-05-17 2023-08-12 rat
Stephan Steidl, Anthony D Miller, Charles D Blaha, John S Yeoman. M₅ muscarinic receptors mediate striatal dopamine activation by ventral tegmental morphine and pedunculopontine stimulation in mice. PloS one. vol 6. issue 11. 2012-05-08. PMID:22102904. however, cholinergic inputs from the laterodorsal (ldt) and pedunculopontine (ppt) tegmental nucleus to the vta and substantia nigra (sn) importantly contribute, as either ldt or ppt lesions strongly attenuate morphine-induced forebrain dopamine elevations. 2012-05-08 2023-08-12 mouse
Almas Siddiqui, Jyothi K Mallajosyula, Anand Rane, Julie K Anderse. Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression. Neurobiology of disease. vol 43. issue 2. 2012-05-07. PMID:21809503. we previously demonstrated that elevation of astrocytic monoamine oxidase b (mao-b) levels in adoxycycline (dox)-inducible transgenic mouse model following 14 days of dox induction results in several neuropathologic features similar to those observed in the parkinsonian midbrain (mallajosyula et al., 2008).these include a specific, selective and progressive loss of dopaminergic neurons of the substantia nigra (sn),selective decreases in mitochondrial complex i (ci) activity and increased oxidative stress. 2012-05-07 2023-08-12 mouse
Chang-Liang Xu, Qi-Zhi Wang, Ling-Mei Sun, Xiu-Min Li, Ji-Min Deng, Lu-Fan Li, Jin Zhang, Rong Xu, Shi-Ping M. Asiaticoside: attenuation of neurotoxicity induced by MPTP in a rat model of Parkinsonism via maintaining redox balance and up-regulating the ratio of Bcl-2/Bax. Pharmacology, biochemistry, and behavior. vol 100. issue 3. 2012-05-04. PMID:22001429. on 14th day, the rats were sacrificed, substantia nigra (sn) and striatum were dissected, and then dopamine (da) and its metabolites in striatum and malonyldialdehyde (mda) contents, reduced glutathione (gsh) level and gene expression level in sn were estimated. 2012-05-04 2023-08-12 rat
Masayuki Miyamoto, Tomoyuki Miyamoto, Masaoki Iwanami, Shin-Ichi Muramatsu, Sayaka Asari, Imaharu Nakano, Koichi Hirat. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder. Sleep medicine. vol 13. issue 1. 2012-05-02. PMID:22033122. transcranial sonography (tcs) has been shown to reveal hyperechogenicity of the substantia nigra (sn) in people with parkinson's disease and in approximately 10% of healthy subjects. 2012-05-02 2023-08-12 human
Knut Busse, Robert Heilmann, Sabine Kleinschmidt, Mazen Abu-Mugheisib, Jacqueline Höppner, Christian Wunderlich, Irene Gemende, Lara Kaulitz, Alexander Wolters, Reiner Benecke, Uwe Walte. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry. vol 83. issue 4. 2012-04-27. PMID:22362921. characteristic features of parkinson's disease (pd) are asymmetric parkinsonian motor signs, hyposmia and substantia nigra (sn) hyperechogenicity on transcranial ultrasound. 2012-04-27 2023-08-12 Not clear
Dae-Hyuk Kwon, Jong-Min Kim, Se-Hong Oh, Hye-Jin Jeong, Sung-Yeon Park, Eung-Seok Oh, Je-Geun Chi, Young-Bo Kim, Beom S Jeon, Zang-Hee Ch. Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Annals of neurology. vol 71. issue 2. 2012-04-26. PMID:22367998. to investigate anatomical changes in the substantia nigra (sn) of parkinson disease (pd) patients with age-matched controls by using ultra-high field magnetic resonance imaging (mri). 2012-04-26 2023-08-12 Not clear
Silvia Tapia-González, Rosa M Giráldez-Pérez, M Isabel Cuartero, M José Casarejos, M Ángeles Mena, Xiao-Fan Wang, Amelia Sánchez-Capel. Dopamine and α-synuclein dysfunction in Smad3 null mice. Molecular neurodegeneration. vol 6. 2012-04-24. PMID:21995845. parkinson's disease (pd) is characterized by dopaminergic neurodegeneration in the substantia nigra (sn). 2012-04-24 2023-08-12 mouse
Alexander Ternianov, José M Pérez-Ortiz, María E Solesio, María S García-Gutiérrez, Antonio Ortega-Álvaro, Francisco Navarrete, Carlos Leiva, María F Galindo, Jorge Manzanare. Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. Neurobiology of aging. vol 33. issue 2. 2012-04-19. PMID:20980074. tyrosine hydroxylase (th), glial fibrillary acidic protein (gfap), and ionized calcium-binding adapter molecule 1 (iba-1) were measured by immunocytochemistry in the cpu and/or substantia nigra (sn) of cb2xp mice and wt mice. 2012-04-19 2023-08-12 mouse
Christina E Khodr, Mohan K Sapru, Jyothi Pedapati, Ye Han, Neva C West, Adrian P Kells, Krystof S Bankiewicz, Martha C Boh. An α-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons. Brain research. vol 1395. 2012-04-19. PMID:21565333. effects of silencing ectopically expressed hsnca in rat substantia nigra (sn) were examined as a novel therapeutic approach to parkinson's disease (pd). 2012-04-19 2023-08-12 rat
Daniel R van Bregt, Theresa Currier Thomas, Jason M Hinzman, Tuoxin Cao, Mei Liu, Guoying Bing, Greg A Gerhardt, James R Pauly, Jonathan Lifshit. Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat. Experimental neurology. vol 234. issue 1. 2012-04-19. PMID:22178300. clinical symptomatology is the likely phenotype of chronic degeneration and circuit disruption in the substantia nigra (sn). 2012-04-19 2023-08-12 rat
Tae Woo Kim, Younghye Moon, Kyungjin Kim, Jeong Eun Lee, Hyun Chul Koh, Im Joo Rhyu, Hyun Kim, Woong Su. Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases. PloS one. vol 6. issue 10. 2012-04-06. PMID:22043283. parkinson's disease (pd) is a common, late-onset movement disorder with selective degeneration of dopaminergic (da) neurons in the substantia nigra (sn). 2012-04-06 2023-08-12 mouse
G Harish, C Venkateshappa, Anita Mahadevan, Nupur Pruthi, M M Srinivas Bharath, S K Shanka. Glutathione metabolism is modulated by postmortem interval, gender difference and agonal state in postmortem human brains. Neurochemistry international. vol 59. issue 7. 2012-04-03. PMID:21945455. to evaluate the effect of these variables, we tested whether antioxidant enzymes [superoxide dismutase (sod), catalase] glutathione (gsh) and related enzymes [gamma glutamylcysteine ligase (gcl), gsh peroxidase (gpx), gsh reductase (gr), gsh-s-transferase (gst)] and malondialdehyde (mda, marker of lipid peroxidation) are affected in postmortem human brains (n=50) by increase in postmortem interval (2.5-26 h), gender difference and agonal state [based on glasgow coma scale (gcs): range: 3-15] in different anatomical regions-frontal cortex (fc), cerebellum (cb) medulla oblongata (mo), substantia nigra (sn) and hippocampus (hc). 2012-04-03 2023-08-12 human
Seung-Nam Kim, Ah-Reum Doo, Ji-Yeun Park, Hyungjin Bae, Younbyoung Chae, Insop Shim, Hyangsook Lee, Woongjoon Moon, Hyejung Lee, Hi-Joon Par. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease. PloS one. vol 6. issue 11. 2012-04-02. PMID:22132113. parkinson's disease (pd) is caused by the selective loss of dopaminergic neurons in the substantia nigra (sn) and the depletion of striatal dopamine (da). 2012-04-02 2023-08-12 mouse
Zhen Zhang, Keke Zhang, Xinrui Du, Yanbin L. Neuroprotection of desferrioxamine in lipopolysaccharide-induced nigrostriatal dopamine neuron degeneration. Molecular medicine reports. vol 5. issue 2. 2012-03-30. PMID:22076309. inflammation and iron accumulation in the substantia nigra (sn) are implicated in the pathogenesis of parkinson's disease (pd). 2012-03-30 2023-08-12 mouse
Peng Lei, Scott Ayton, David I Finkelstein, Loredana Spoerri, Giuseppe D Ciccotosto, David K Wright, Bruce X W Wong, Paul A Adlard, Robert A Cherny, Linh Q Lam, Blaine R Roberts, Irene Volitakis, Gary F Egan, Catriona A McLean, Roberto Cappai, James A Duce, Ashley I Bus. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nature medicine. vol 18. issue 2. 2012-03-29. PMID:22286308. neuronal iron accumulation has been observed pathologically in the cortex in alzheimer's disease, the substantia nigra (sn) in parkinson's disease and various brain regions in the tauopathies. 2012-03-29 2023-08-12 mouse